CKAP2L and nonpapillary renal cell carcinoma: Gene enrichment analysis, including GSEA and GSVA, finds that CKAP2L might boost ccRCC by activating a series of vital tumor-related pathways, such as the JAK–STAT signaling pathway, the P53 signaling pathway, and the TGF-β signaling pathway.